Analyst Consensus ?
ConsensusBuy25 ratings
Bullish1768.0%
Neutral728.0%
Bearish14.0%
FN2 Earnings Intelligence
Philip Morris International Inc. (PM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 23, 2026 |
| Needham | Buy | Buy | Maintain | Jul 23, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 23, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 2, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jan 20, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Nov 26, 2025 |
| B of A Securities | Buy | Buy | Maintain | Jun 4, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 1, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Sep 26, 2024 |
| Argus Research | Hold | Buy | Downgrade | Mar 5, 2024 |
| Societe Generale | Hold | Sell | Upgrade | Feb 13, 2024 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Feb 13, 2020 |
| Piper Sandler | Overweight | Overweight | Maintain | Jan 7, 2020 |
| Wells Fargo | Outperform | Outperform | Maintain | Oct 18, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Oct 1, 2019 |
| Credit Suisse | Underperform | Neutral | Downgrade | Dec 18, 2018 |
| Argus | Buy | Hold | Upgrade | Jul 25, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 20, 2018 |
| SBG Securities | Hold | Sell | Upgrade | Aug 11, 2017 |
| CLSA | Buy | Outperform | Maintain | Nov 14, 2016 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Mar 8, 2016 |
| Nomura | Neutral | Reduce | Upgrade | Nov 30, 2015 |
| FirstEnergy Capital | Market Perform | Outperform | Downgrade | Feb 21, 2014 |
Upside is calculated against the persisted current price $191.16. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Pallav Mittal | $225 | $200.17 | +17.7% | Jul 29, 2026 |
| BTIG | Analyst unavailable | $221 | $191.12 | +15.6% | Jul 24, 2026 |
| Stifel Nicolaus | Analyst unavailable | $205 | $194.3 | +7.2% | Jul 23, 2026 |
| Needham | Gerald Pascarelli | $215 | $194.3 | +12.5% | Jul 23, 2026 |
| Morgan Stanley | Analyst unavailable | $215 | $194.3 | +12.5% | Jul 23, 2026 |
| BTIG | Analyst unavailable | $216 | $188.04 | +13.0% | Jul 21, 2026 |
| UBS | Analyst unavailable | $182 | $180.7 | -4.8% | Jul 2, 2026 |
| Morgan Stanley | Analyst unavailable | $200 | $173.66 | +4.6% | Jun 3, 2026 |
| UBS | Analyst unavailable | $168 | $157.11 | -12.1% | Apr 17, 2026 |
| Morgan Stanley | Eric Serotta | $190 | $156.58 | -0.6% | Apr 17, 2026 |
| Stifel Nicolaus | Matthew Smith | $195 | $158.68 | +2.0% | Apr 10, 2026 |
| Barclays | Analyst unavailable | $205 | $183.4 | +7.2% | Feb 23, 2026 |
| UBS | Analyst unavailable | $181.5 | $180.24 | -5.1% | Feb 9, 2026 |
| Morgan Stanley | Eric Serotta | $205 | $182.81 | +7.2% | Feb 9, 2026 |
| Stifel Nicolaus | Analyst unavailable | $200 | $182.81 | +4.6% | Feb 9, 2026 |
| Jefferies | Edward Mundy | $180 | $173.62 | -5.8% | Jan 20, 2026 |
| Morgan Stanley | Eric Serotta | $175 | $152 | -8.5% | Oct 22, 2025 |
| Stifel Nicolaus | Analyst unavailable | $180 | $152 | -5.8% | Oct 22, 2025 |
| Stifel Nicolaus | Matthew Smith | $186 | $150.17 | -2.7% | Oct 21, 2025 |
| UBS | Faham Baig | $181 | $180.37 | -5.3% | Jul 14, 2025 |
| Barclays | Gaurav Jain | $155 | $131.57 | -18.9% | Oct 30, 2024 |
| Deutsche Bank | Damian McNeela | $142 | $131.41 | -25.7% | Oct 22, 2024 |
| Citigroup | Simon Hales | $132 | $118.91 | -30.9% | Oct 8, 2024 |
| Deutsche Bank | Damian McNeela | $135 | $121.4 | -29.4% | Oct 1, 2024 |
| Barclays | Gaurav Jain | $145 | $125.81 | -24.1% | Sep 9, 2024 |
| Bank of America Securities | Lisa Lewandowski | $139 | $125.71 | -27.3% | Sep 4, 2024 |
| Stifel Nicolaus | Matthew Smith | $138 | $125.71 | -27.8% | Sep 4, 2024 |
| Stifel Nicolaus | Matthew Smith | $115 | $110.24 | -39.8% | Jul 24, 2024 |
| Stifel Nicolaus | Matthew Smith | $120 | $109.56 | -37.2% | Jul 24, 2024 |
| Goldman Sachs | Bonnie Herzog | $118 | $94.06 | -38.3% | Apr 23, 2024 |
| Morgan Stanley | Pamela Kaufman | $113 | $90.27 | -40.9% | Oct 3, 2023 |
| Argus Research | David Coleman | $110 | $98.77 | -42.5% | Jul 20, 2023 |
| Morgan Stanley | Pamela Kaufman | $118 | $97.36 | -38.3% | Jun 29, 2023 |
| Jefferies | Stephanie Wissink | $150 | $95.08 | -21.5% | May 4, 2023 |
| Stifel Nicolaus | Matthew Smith | $114 | $98.16 | -40.4% | Apr 24, 2023 |
| Jefferies | Analyst unavailable | $99 | $90.6 | -48.2% | Jul 19, 2022 |
| Credit Suisse | Lauren Silberman | $130 | $98.16 | -32.0% | May 6, 2022 |
| Bank of America Securities | Lisa Lewandowski | $117 | $102.69 | -38.8% | Apr 24, 2022 |
| Morgan Stanley | Pamela Kaufman | $112 | $103.53 | -41.4% | Apr 22, 2022 |
| Stifel Nicolaus | Christopher Growe | $105 | $93.94 | -45.1% | Mar 30, 2022 |
| UBS | Nik Oliver | $110 | $111.61 | -42.5% | Feb 21, 2022 |
| Bernstein | Callum Elliott | $107 | $91.94 | -44.0% | Jun 1, 2021 |
Track every rating change on PM the moment it posts. Free to start.
Start free